Is this competition of any means for Telix - not radiopharma but with regards to prostate cancer drug in the broader sense/longer term? Or not at all since TLX is so planning anything in Africa any time soon anyway? What is the current efficacy of such treatments? Interested in your opinion.
https://www.debiopharm.com/drug-development/press-releases/debiopharm-and-aspen-partner-to-launch-prostate-cancer-drug-trelstar-in-south-africa/
Lausanne, Switzerland and Durban, South Africa – February 1st, 2022
Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company and Aspen, a South African headquartered multinational pharmaceutical company announced today their partnership to launch Trelstar® (Triptorelin) in South Africa for the treatment of locally advanced and metastatic hormone dependent prostate cancer. (Trelstar®, a synthetic analogue of GnRH (Gonadotropin Releasing Hormone) developed by Debiopharm, will be marketed by Aspen in South Africa.
In 2020, nearly 14,000 South African men were newly diagnosed with prostate cancer with an average of 5 men dying from the disease every day. In fact, 1 in every 23 South African men will develop prostate cancer in their lifetime. Trelstar works by reducing testosterone levels, a hormone essential to prostate cancer growth. Deprivation of testosterone stops the growth of hormone dependent prostate cancer, alleviating pain and improving the quality of life of patients.
We’re really enthusiastic to enter into this new alliance with Aspen, a well-established and trusted pharmaceutical partner for the commercialization of Trelstar® in South Africa and recognize the therapeutic benefits that Trelstar® could bring to prostate cancer patients in this region. Fabrice Paradies, Senior Director, Business Development & Global Commercial Alliances, Debiopharm.
Aspen Pharmacare is excited to be able to deliver a world class oncology product in the treatment of prostate cancer and we are privileged to partner with Debiopharm to commercialize Trelstar® within the South African market. We are confident that this product will add significant benefit to the treatment of prostate cancer. Neel Andhee-Shah, Head: New Product Development, Aspen Pharmacare.
About Trelstar® (Triptorelin)
Trelstar® (Triptorelin) is an agonist analogue of the natural gonadotropin-releasing hormone (GnRH). Debiopharm has developed three sustained-release formulations (1, 3 and 6 months) of Triptorelin Pamoate. First registered in France in 1986, Triptorelin is currently marketed in more than 80 countries by Debiopharm’s selected partners and is market leader in many territories worldwide.
About Aspen
Headquartered in Durban, South Africa, Aspen is a partner of choice as it is a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets. Aspen improves the health of patients in more than 150 countries through its high quality and affordable medicines. Active at every stage of the value chain, Aspen is uniquely diversified by geography, product and manufacturing capability. The Group’s key business segments are Manufacturing and Commercial Pharmaceuticals comprising Regional Brands and Sterile Focus Brands.
- Forums
- ASX - By Stock
- TLX
- Competition
Competition, page-35
-
- There are more pages in this discussion • 220 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
|
|||||
Last
$19.83 |
Change
0.305(1.56%) |
Mkt cap ! $6.645B |
Open | High | Low | Value | Volume |
$19.85 | $20.00 | $19.70 | $11.68M | 588.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 299 | $19.82 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.83 | 947 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 210 | 19.820 |
5 | 447 | 19.810 |
6 | 555 | 19.800 |
6 | 927 | 19.790 |
8 | 2804 | 19.780 |
Price($) | Vol. | No. |
---|---|---|
19.830 | 250 | 4 |
19.840 | 567 | 12 |
19.850 | 744 | 9 |
19.860 | 955 | 12 |
19.870 | 1018 | 8 |
Last trade - 12.26pm 20/08/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |